Literature DB >> 7533292

A macrophage receptor for oxidized low density lipoprotein distinct from the receptor for acetyl low density lipoprotein: partial purification and role in recognition of oxidatively damaged cells.

E Ottnad1, S Parthasarathy, G R Sambrano, M P Ramprasad, O Quehenberger, N Kondratenko, S Green, D Steinberg.   

Abstract

The binding and uptake of oxidatively modified low density lipoprotein (OxLDL) by mouse peritoneal macrophages occurs, in part, via the well characterized acetyl LDL receptor. However, several lines of evidence indicate that as much as 30-70% of the uptake can occur via a distinct receptor that recognizes OxLDL with a higher affinity than it recognizes acetyl LDL. We describe the partial purification and characterization of a 94- to 97-kDa plasma membrane protein from mouse peritoneal macrophages that specifically binds OxLDL. This receptor is shown to be distinct from the acetyl LDL receptor as well as from two other macrophage proteins that also bind OxLDL--the Fc gamma RII receptor and CD36. We suggest that this OxLDL-binding membrane protein participates in uptake of OxLDL by murine macrophages and also represents a receptor responsible for macrophage binding and phagocytosis of oxidatively damaged cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7533292      PMCID: PMC42525          DOI: 10.1073/pnas.92.5.1391

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

Authors:  R J HAVEL; H A EDER; J H BRAGDON
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts.

Authors:  S K Basu; J L Goldstein; G W Anderson; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

5.  Isolation of rat liver plasma membrane fragments in isotonic sucrose.

Authors:  N N Aronson; O Touster
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

6.  Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor.

Authors:  I Fraser; D Hughes; S Gordon
Journal:  Nature       Date:  1993-07-22       Impact factor: 49.962

7.  Enhanced macrophage degradation of biologically modified low density lipoprotein.

Authors:  T Henriksen; E M Mahoney; D Steinberg
Journal:  Arteriosclerosis       Date:  1983 Mar-Apr

8.  Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenyl glycoluril (Iodogen).

Authors:  P R Salacinski; C McLean; J E Sykes; V V Clement-Jones; P J Lowry
Journal:  Anal Biochem       Date:  1981-10       Impact factor: 3.365

9.  Rat liver Kupffer and endothelial cells express different binding proteins for modified low density lipoproteins. Kupffer cells express a 95-kDa membrane protein as a specific binding site for oxidized low density lipoproteins.

Authors:  Y B de Rijke; T J van Berkel
Journal:  J Biol Chem       Date:  1994-01-14       Impact factor: 5.157

10.  Evolution of foam cells in subcutaneous rabbit carrageenan granulomas: I. Light-microscopic and ultrastructural study.

Authors:  C J Schwartz; J J Ghidoni; J L Kelley; E A Sprague; A J Valente; C A Suenram
Journal:  Am J Pathol       Date:  1985-01       Impact factor: 4.307

View more
  30 in total

1.  Macrophages lacking scavenger receptor A show a decrease in binding and uptake of acetylated low-density lipoprotein and of apoptotic thymocytes, but not of oxidatively damaged red blood cells.

Authors:  V Terpstra; N Kondratenko; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  Human cytomegalovirus increases modified low density lipoprotein uptake and scavenger receptor mRNA expression in vascular smooth muscle cells.

Authors:  Y F Zhou; E Guetta; Z X Yu; T Finkel; S E Epstein
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

3.  Involvement of phospholipids in apolipoprotein B modification during low density lipoprotein oxidation.

Authors:  A I Karakatsani; T A Liapikos; A N Troganis; D C Tsoukatos
Journal:  Lipids       Date:  1998-12       Impact factor: 1.880

4.  Role for the class A macrophage scavenger receptor in the phagocytosis of apoptotic thymocytes in vitro.

Authors:  N Platt; H Suzuki; Y Kurihara; T Kodama; S Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

5.  Multiple systems for recognition of apoptotic lymphocytes by macrophages.

Authors:  D Pradhan; S Krahling; P Williamson; R A Schlegel
Journal:  Mol Biol Cell       Date:  1997-05       Impact factor: 4.138

6.  Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cells.

Authors:  B Smedsrød; J Melkko; N Araki; H Sano; S Horiuchi
Journal:  Biochem J       Date:  1997-03-01       Impact factor: 3.857

Review 7.  Pleiotropic role of PPARγ in intracerebral hemorrhage: an intricate system involving Nrf2, RXR, and NF-κB.

Authors:  Xiu-Rong Zhao; Nicole Gonzales; Jaroslaw Aronowski
Journal:  CNS Neurosci Ther       Date:  2014-11-28       Impact factor: 5.243

8.  Proteoglycans in macrophages: characterization and possible role in the cellular uptake of lipoproteins.

Authors:  B Halvorsen; U K Aas; M A Kulseth; C A Drevon; E N Christiansen; S O Kolset
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

9.  Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice.

Authors:  M Febbraio; E A Podrez; J D Smith; D P Hajjar; S L Hazen; H F Hoff; K Sharma; R L Silverstein
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

10.  The fornix provides multiple biomarkers to characterize circuit disruption in a mouse model of Alzheimer's disease.

Authors:  Alexandra Badea; Lauren Kane; Robert J Anderson; Yi Qi; Mark Foster; Gary P Cofer; Neil Medvitz; Anne F Buckley; Andreas K Badea; William C Wetsel; Carol A Colton
Journal:  Neuroimage       Date:  2016-08-10       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.